The morning opened up on a high note for this dually-listed company as it announced U.S. Food and Drug Administration (FDA) approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501 )....

To read the full story on AllPennyStocks.com, click here.

Appili Therapeutics (TSX:APLI)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Appili Therapeutics
Appili Therapeutics (TSX:APLI)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Appili Therapeutics